Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes

M.M. Smits, L. Tonneijck, M.H.A. Muskiet, T. Hoekstra, M.H.H. Kramer, I.C. van den Pieters-van den Bos, D.L. Cahen, M. Diamant, D.H. van Raalte

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Article numbere009579
JournalBMJ Open
Volume5
Issue number11
DOIs
Publication statusPublished - 2015

Cite this